Brief: Aspire Biopharma Enters Agreement To Sell $9.69 Million Notes
22/08/2025 23:36
Aug 22 (Reuters) - Aspire Biopharma Holdings Inc ASBP.O: ASPIRE BIOPHARMA HOLDINGS INC - ON AUG 19, ENTERS AGREEMENT TO SELL $9.69 MILLION NOTES - SEC FILING ASPIRE BIOPHARMA HOLDINGS INC - TO USE PROCEEDS TO PAY OFF DEBT - SEC FILING Source text: [ID:n0001641172-25-025257] Further company coverage: ASBP.O ((Reuters.Briefs@thomsonreuters.com;))